Our Science
At AccSalus, we are at the forefront in the design of precision medicine, focusing on the design of small molecule drugs that function as kinase inhibitors, to address critical areas such as [oncology.|autoimmune diseases.|central nervous system disorders.]
As we expand, we have plans to extend our expertise into the design of large molecules drugs and vaccines.
In 2023, a total of
AccSalus has strategically addressed these challenges through innovative solutions:
This sophisticated system operates without human intervention throughout the virtual screening process with efficiency and precision.
Furthermore, our reliable wet lab facilities are cost-effective operations, allowing us to accelerate drug discovery while maintaining financial discipline.
AccSalus AI Algorithm Platform
Start From
Extremely large databases
CompGens
• Efficient generation of virtual compounds in the order of trillions
• Compound core structure diversity
HitFinder
Targeted drug design:
• Multi-target drugs
• Highly selective hits
• BBB penetration hits
Deep Learning
• Deep learning based on experimental data to create AI knowledge base
• Knowledge base automatically updates for deep learning
The Result
Virtual drug compounds for laboratory synthesis
Through this advanced AI Algorithm Platform, AccSalus accelerates the timeline from target identification to drug candidate, all while keeping costs significantly below industry standards.
More to explore
